Jacobson Pharma Corporation Limited (2633) Stock Statistics & Valuation Metrics

Jacobson Pharma Corporation Limited has a market cap or net worth of HK$2.81B. The enterprise value is HK$2.63B.

Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jacobson Pharma Corporation Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.96%.

The current PE Ratio of Jacobson Pharma Corporation Limited is 9.8. Jacobson Pharma Corporation Limited’s PEG ratio is ―.

In the last 12 months, Jacobson Pharma Corporation Limited had revenue of 1.58B and earned 300.83M in profits. Earnings per share was 0.15.

In the last 12 months, operating cash flow was 495.44M and capital expenditures -65.47M, giving a free cash flow of 429.97M billion.

Jacobson Pharma Corporation Limited pays an annual dividend of HK$0.055, resulting in a dividend yield of 4.03%

Jacobson Pharma Corporation Limited upcoming earnings date is Nov 21, 2025, TBA (Confirmed).

Jacobson Pharma Corporation Limited as a current ratio of 1.88, with Debt / Equity ratio of 31.52%

In the past 12 months, Jacobson Pharma Corporation Limited has paid 72.79M in taxes.

Jacobson Pharma Corporation Limited EV to EBITDA ratio is 4.67, with an EV/FCF ratio of 9.37.

Jacobson Pharma Corporation Limited has HK$563.79M in cash and marketable securities with HK$699.85M in debt, giving a net cash position of HK$136.06M billion.

Gross margin is 43.94%, with operating margin of 26.29%, and net profit margin of 19.08%.

The average price target for Jacobson Pharma Corporation Limited is HK$1.50, which is 11.43% higher than the current price. The consensus rating is Hold